Masao Tomonaga - Concepedia

Author

Masao Tomonaga

Also Known As

K. Fujimoto, M TOMONAGA, M Tomonaga, M. TOMONAGA, M. Tomonaga, MASAO TOMONAGA, MASAO TOMONAGA, M.D., Masao TOMONAGA, Masao Tomonaga, Tomonaga, Masao

447

Publications

14.9K

Citations

H-Index

156

Concepts

All Affiliations

Nagasaki University Sasebo City General Hospital Nagasaki University Hospital Nagoya University University of the Ryukyus

About

Masao Tomonaga is an author at Nagasaki University specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	101	5.7K
2	Health Sciences	16	21	1K
3	Engineering	3	3	438
4	Law	1	1	132
5	Natural Sciences	1	1	14

Masao Tomonaga

197

Publications

14.2K

Citations

H-Index

Page 1

	Year	Citations
Cancer Incidence in Atomic Bomb Survivors. Part III: Leukemia, Lymphoma and Multiple Myeloma, 1950-1987 Dale L. Preston, Shizuyo Kusumi, Masao Tomonaga, Radiation Research Mixed-phenotype Acute LeukemiaRadiation ExposurePathologyCancer IncidenceAtomic Bomb Survivors	1994	799
Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study Takashi Ishida, Tatsuro Joh, Naokuni Uike, Journal of Clinical Oncology	2012	639
VCAP-AMP-VECP Compared With Biweekly CHOP for Adult T-Cell Leukemia-Lymphoma: Japan Clinical Oncology Group Study JCOG9801 Kunihiro Tsukasaki, Atae Utsunomiya, Haruhiko Fukuda, Journal of Clinical Oncology	2007	478
Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia Ryuzo Ohno, Masao Tomonaga, Tohru Kobayashi, New England Journal of Medicine	1990	396
The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950–2001 Wan‐Ling Hsu, Dale L. Preston, Midori Soda, Radiation Research EngineeringRadiation EffectRadiation ExposurePathologyLeukemia Excess Risks	2013	394
Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma Michinori Ogura, Takashi Ishida, Kiyohiko Hatake, Journal of Clinical Oncology	2014	357
A new G‐CSF‐supported combination chemotherapy, LSG15, for adult T‐cell leukaemia‐lymphoma: Japan Clinical Oncology Group Study 9303 Yasuaki Yamada, Masao Tomonaga, Haruhiko Fukuda, British Journal of Haematology	2001	353
Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma Kazuhito Yamamoto, Atae Utsunomiya, Kensei Tobinai, Journal of Clinical Oncology	2010	350
ICSH guidelines for the standardization of bone marrow specimens and reports Sang‐Hee Lee, Wendy N. Erber, Anna Porwit, International Journal of Laboratory Hematology	2008	305
Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Naoki Mori, Masahiro Fujii, Shu‐ichi Ikeda, PubMed	1999	286

Page 1